Recurrent Episodes of Paraphilic Behavior Possibly Associated With Olanzapine and Aripiprazole Treatment in a Patient With Schizophrenia

Bibliographic Data

ID15518964
AuthorsMaria‐Ioanna Stefanou (0000-0002-2305-6627, University of Tübingen, corresponding author), Maria-Ioanna Stefanou, Debora Vittore (University of Tübingen), Ines Wolz (0000-0001-8338-3948, University of Tübingen), Stefan Klingberg (0000-0001-8081-7181, University of Tübingen), Dirk Wildgruber (0000-0003-3047-5173, University of Tübingen)
Year2020
Volume11
Pages318-318
Publication date2020-04-20
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2020.00318
PMID32425825
OpenAlexW3019453800
LanguageEN
Citations received1
References cited39

This case illustrates that hypersexuality may be a rare adverse effect of treatment with second-generation antipsychotics. Although aripiprazole is a drug with a well-established risk for hypersexuality, the question of whether a causal association between hypersexuality and olanzapine exists remains currently unresolved. As the currently limited amount of available evidence precludes any definitive conclusions, additional research is warranted to delineate the possible neurobiological substrates of hypersexual and paraphilic disorders in patients treated with second-generation antipsychotics

Akathisia · Amisulpride · Antipsychotic · Aripiprazole · Atypical antipsychotic · Discontinuation · Extrapyramidal symptoms · Hypersexuality · Olanzapine · Paranoid schizophrenia · Psychiatry · Psychosis · Quetiapine · Risperidone · Schizophrenia (object-oriented programming · Sexual behavior · Clinical Psychology · Medicine · Neurotransmitter Receptor Influence on Behavior · Obsessive-Compulsive Spectrum Disorders · Psychology · Sexuality, Behavior, and Technology

Tools

Open DOISci-HubOpen Access